Brief: Seres Therapeutics Reports Q1 2023 Financial Results And Provides Business Updates
09/05/2023 12:27
May 9 (Reuters) - Seres Therapeutics Inc MCRB.O :
* SERES THERAPEUTICS REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS
AND PROVIDES BUSINESS UPDATES
* QTRLY LOSS PER SHARE $0.57
* Q1 EARNINGS PER SHARE VIEW $-0.55 -- REFINITIV IBES DATA
Source text for Eikon: ID:nBw3QJNk2a
Further company coverage: MCRB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Seres Therapeutics
See all newsChinese automakers make tech-led pitch for Europe's premium car market
Brief: Seres Therapeutics - May Offer Up To $300 Million Of Securities
Seres Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Seres Therapeutics Q2 net income turns positive on VOWST sale gain
Brief: Seres Therapeutics Q2 EPS USD 0.47